Zhicheng Jin

8PUBLICATIONS
28CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 10, 2026
Reply to: Different Stage But Similar Survival in Hepatocellular Carcinoma: A Dilemma of Treatment Timing?

|Jun 02, 2026
Cisplatin Dose Differences Affect Chemoembolization Efficacy.

|Mar 31, 2026
Camrelizumab and Apatinib With or Without Transarterial Chemoembolisation as First-Line Treatment for Advanced Hepatocellular Carcinoma.

Rong Ding, Jin-Feng Bai, Zhi-Cheng Jin

|Feb 24, 2026
Transarterial Chemoembolization Combined With Camrelizumab and Rivoceranib for Unresectable Hepatocellular Carcinoma (CHANCE2005/CARES-005): A Randomized Phase II Trial.

Hai-Dong Zhu, Wei-Jun Fan, Chang Zhao

|Jul 28, 2025
Artificial intelligence-driven pathomics in hepatocellular carcinoma: current developments, challenges and perspectives.

Wei Ding, Jinxing Zhang, Zhicheng Jin

|Feb 19, 2024
Locoregional therapies for hepatocellular carcinoma: The current status and future perspectives.

Jian-Jian Chen, Zhi-Cheng Jin, Bin-Yan Zhong

Pageof 2

Frequent Collaborators

4 joint publications

Hai-Dong Zhu

3 joint publications

Bin-Yan Zhong

3 joint publications

Gao-Jun Teng

2 joint publications

Gao-Jun Teng